• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Regional Offices - Improve and standardize the Consumer Complaint Process

Description: Implement the revised FMD-119 in the District Offices, train the consumer complaint coordinators and/or designees, and monitor the effectiveness of the revised procedures.

Briefing Status: COMPLETED

Prior Briefing Status: ON TRACK

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

1. Assemble a team of SME to conduct a review and evaluate new process

4/2/2012

Completed 4/2/2012

2. Assess the consumer complaint workload per district to determine the resources needed to implement the revised FMD

5/1/2012

Completed 5/9/2012

3. Develop a training conference for consumer complaint coordinators and/or designees in order to facilitate the standardization of the consumer complaint process

6/1/2012

Completed 6/1/2012

4. Conduct training conference for Consumer Complaint SCSOs to learn new process

9/30/2012

Completed 9/12/2012

5. Analyze and monitor the effectiveness of the revised procedure

12/30/2012

Completed 10/26/2012

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.